Research Library › Compound research
Kisspeptin-10 research examines a short kisspeptin peptide in defined receptor and cellular systems. The first step in reading this literature is identifying which kisspeptin form was tested and keeping its experimental context attached to the result.
What is Kisspeptin-10?
Kisspeptin-10 is the C-terminal decapeptide amide associated with the longer kisspeptin-54, also called metastin [1]. “Decapeptide” identifies a ten-residue peptide; the terminal form is also part of the material’s identity.
Kisspeptin-10, kisspeptin-54, and modified receptor agonists are related research materials, but their names should not be treated as interchangeable. A paper that studies one form does not automatically characterize another form or a current commercial batch.
Which receptor framework appears in the literature?
Foundational research by Kotani and colleagues identified kisspeptins as ligands of GPR54, now commonly called KISS1R [2]. That paper studied longer kisspeptin forms and described receptor-associated responses in engineered cell systems. It provides background for the peptide family rather than a direct test of a Not Labs Kisspeptin-10 lot.
Record the receptor terminology used in each paper. Different names can refer to the same receptor, while different peptide names can refer to distinct ligands. Checking both prevents a terminology match from becoming an unsupported material match.
Why does the exact peptide form matter?
Tomita and colleagues investigated structure–activity relationships of small peptidic GPR54 agonists in 2006 [1]. Their work illustrates why sequence changes and analog design belong in the interpretation of receptor activity. Findings involving a modified agonist should remain attached to that tested structure.
When reviewing a certificate or study, check the sequence specification, terminal modification, material form, and intended analyte. A broad “kisspeptin” label is less informative than a record identifying the particular material.
Which endpoints should be distinguished?
- Binding: evidence about ligand–receptor interaction under the assay conditions.
- Signaling: the specific intracellular response being measured.
- Cell behavior: a downstream observation that may depend on the cellular model.
- Endocrine measurements: a separate experimental context that should not be inferred from a receptor assay alone.
Do not collapse these into a general statement about hormone support, fertility, or performance. An endpoint in an engineered cell system and an observation in an organism answer different questions.
How can studies be compared carefully?
Record the exact ligand, receptor species, cell system, controls, measurement method, and observation period. Check whether the study evaluates native Kisspeptin-10 or an analog and whether the conclusion concerns binding, signaling, or a downstream endpoint.
A receptor-expressing model may behave differently from a model with different expression or background signaling. Interpret a reported response within that model. Comparisons across unrelated studies require more context than matching compound names or selecting the largest numerical response.
What should be reviewed before selecting research material?
Start with the Kisspeptin-10 product documentation and connect the lot identifier to its certificate. Review the intended identity, analytical method, sample information, test date, and reported results.
Identity and chromatographic purity answer different questions. Quantitative content is another separate attribute. None of these alone establishes receptor agonism, biological activity, sterility, or suitability for an experimental application.
Use Testing & Verification and How to Read a Peptide COA to identify which conclusions the batch records support. Keep published research context separate from current lot verification.
Primary references
- Tomita et al. (2006). Structure-activity relationship study on small peptidic GPR54 agonists. Bioorganic & Medicinal Chemistry, 14(22), 7595–7603.
- Kotani et al. (2001). The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. Journal of Biological Chemistry, 276(37), 34631–34636.